Cover Image
市場調查報告書

美國的介入心臟病學產品市場

U.S. Markets for Interventional Cardiology Products

出版商 Medtech Insight 商品編碼 118793
出版日期 內容資訊 英文 270 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的介入心臟病學產品市場 U.S. Markets for Interventional Cardiology Products
出版日期: 2014年05月01日 內容資訊: 英文 270 Pages
簡介

2013年美國實施的診斷及治療用介入心臟病學治療大概有550萬件,產品銷售額的話約為38億美金。2018年預計增加到570萬件左右,產品銷售額達到約43億美元。

本報告提供心臟疾病概要,以及診斷用及治療用的介入心臟病學產品概要、加入該市場的主要企業簡介,為您概述為以下內容。

摘要整理

第1章 心臟疾病概要

  • 心臟和循環系統系
  • 主要的心臟疾病
    • 冠狀動脈心臟病(冠心病)
    • 高血壓
    • 心肌病
    • 先天性心臟缺陷
    • 心臟衰竭

第2章 診斷用介入心臟病學治療及產品

  • 冠動脈攝影術
  • 導管導引線的生理學性血管內狹窄診斷
  • 心臟超音波鏡檢查檢驗
  • 心臟內超音波

第3章 治療用介入心臟病學治療及產品

  • 經皮冠狀動脈擴張術
  • 冠狀動脈支架
  • 旋切術
  • 慢性完全閉塞
  • 藥物釋放型球囊血管新生
  • 血栓切除
  • 經導管中隔缺損修復
  • 血管通路部位阻塞設備

第4章 企業簡介

  • Abbott Laboratories
  • AGA Medical/AGA Medical Holdings, Inc.
  • Arrow International/Teleflex, Inc.
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cordis Corporation/Johnson & Johnson
  • FlowCardia, Inc.
  • InSitu Technologies, Inc.
  • MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • NMT Medical, Inc.
  • OrbusNeich
  • Spectranetics Corporation
  • St. Jude Medical
  • Terumo Corporation
  • Vascular Solutions, Inc.
  • Volcano Corporation

附錄:企業清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: A209

Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from coronary heart disease (CHD), which is the single largest cause of death in the U.S. and also is the greatest cause of premature and permanent disability in the labor force; CHD is responsible for more than 50% of all cardiovascular events in men and women younger than age 75, and for 1 out of every 6 deaths.

Interventional cardiology is a continually evolving area of medicine that involves the use of catheter-based, or transcatheter, tools and techniques to diagnose and treat coronary vascular and structural disorders. Today, interventional techniques, which came into widespread use in the mid-1980s, are a mainstay for the diagnosis and treatment of patients with CHD. In 2013, diagnostic and therapeutic interventional cardiology methods were employed in approximately 5.5 million procedures in the U.S., generating approximately $3.8 billion in corresponding products sales; it is expected that, in the year 2018, these methods will be employed in nearly 5.7 million procedures in the U.S., generating an estimated $4.3 billion in corresponding product sales.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional cardiology devices to the U.S.

Covered topics in this report include atherectomy, cardiovascular disease statistics, coronary angiography, coronary stenting, drug-eluting balloon angioplasty, guidewire-based physiologic intravascular stenosis assessment, intracardiac echocardiography, intravascular ultrasound, percutaneous transluminal coronary angioplasty, thrombectomy, transcatheter septal defect repair, and vascular access site closure, among others.

Table of Contents

EXECUTIVE SUMMARY

  • i. Diagnostic Interventional Cardiology Products
    • a. Coronary Angiography Systems
    • b. Guidewire-Based Physiologic Intravascular Stenosis Assessment Products
    • c. Intracardiac Echocardiography Products
    • d. Intravascular Ultrasound Products
  • ii. Therapeutic Interventional Cardiology Products
    • a. Percutaneous Transluminal Coronary Angiography Devices
    • b. Coronary Stent Systems
    • c. Atherectomy Systems
    • d. Thrombectomy Systems
    • e. Transcatheter Septal Defect Repair Devices
    • f. Vascular Access Site Closure Devices
  • iii. Methodology
  • Exhibit ES-1: Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018
  • Exhibit ES-2: Interventional Cardiology Products, Combined Market Forecast, 2013-2018
  • Exhibit ES-3: Diagnostic Interventional Cardiology Systems Market Share, by Product Segment, 2013 and 2018
  • Exhibit ES-4: Therapeutic Interventional Systems Market Share, by Product Segment, 2013 and 2018

1. HEART DISEASE OVERVIEW

  • 1.1. The Heart and Circulatory System
  • 1.2. Selected Heart Diseases/Disorders
    • 1.2.1. Coronary Heart Disease
      • 1.2.1.1. Atherosclerosis
      • 1.2.1.2. Angina Pectoris
      • 1.2.1.3. Myocardial Infarction
    • 1.2.2. Hypertension
      • 1.2.2.1. Systolic and Diastolic Pressures
      • 1.2.2.2. Prehypertension
    • 1.2.3. Cardiomyopathy
      • 1.2.3.1. Dilated Cardiomyopathy
      • 1.2.3.2. Hypertrophic Cardiomyopathy
      • 1.2.3.3. Restrictive Cardiomyopathy
    • 1.2.4. Congenital Heart Defects
      • 1.2.4.1. Ventricular Septal Defects
      • 1.2.4.2. Atrial Septal Defects
      • 1.2.4.3. Patent Ductus Arteriosus
    • 1.2.5. Heart Failure
      • 1.2.5.1. Disease Development
      • 1.2.5.2. Ejection Fraction Reduction
      • 1.2.5.3. Classification/Staging Systems
  • Exhibit 1-1: Cross-Section Diagram of the Heart
  • Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors
  • Exhibit 1-3: Standard Angina Pectoris Classification
  • Exhibit 1-4: Angina Pectoris, Selected Statistics
  • Exhibit 1-5: Clinical Classification of AMI
  • Exhibit 1-6: Myocardial Infarction, Selected Statistics
  • Exhibit 1-7: Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State
  • Exhibit 1-8: Hypertension, Selected Statistics
  • Exhibit 1-9: Cardiomyopathy, Selected Statistics
  • Exhibit 1-10: Congenital Heart Defects, Selected Statistics
  • Exhibit 1-11: Summary, New York Heart Association Heart Failure Classification System
  • Exhibit 1-12: Summary, ACCF/AHA Failure Staging System
  • Exhibit 1-13: Heart Failure, Selected Statistics

2. DIAGNOSTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS

  • 2.1. Coronary Angiography
    • 2.1.1. Technologies
    • 2.1.2. Procedure Volumes
    • 2.1.3. Products
    • 2.1.4. Market Forecast
    • 2.1.5. Competitors
  • 2.2. Guidewire-Based Physiologic Intravascular Stenosis Assessment
    • 2.2.1. Technologies
    • 2.2.2. Procedure Volumes
    • 2.2.3. Products
    • 2.2.4. Market Forecast
    • 2.2.5. Competitors
  • 2.3. Intracardiac Echocardiography
    • 2.3.1. Technologies
    • 2.3.2. Procedure Volumes
    • 2.3.3. Products
    • 2.3.4. Market Forecast
    • 2.3.5. Competitors
  • 2.4. Intravascular Ultrasound
    • 2.4.1. Technologies
    • 2.4.2. Procedure Volumes
    • 2.4.3. Products
    • 2.4.4. Market Forecast
    • 2.4.5. Competitors
  • Exhibit 2-1: Diagnostic Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-2: Diagnostic Interventional Cardiology Products, Combined Market Forecast, 2013-2018
  • Exhibit 2-3: Coronary Angiography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-4: 2014, Selected Angiography Catheters
  • Exhibit 2-5: 2014, Selected Diagnostic Guidewires
  • Exhibit 2-6: 2014, Selected Introducers/Sheaths
  • Exhibit 2-7: Coronary Angiography Devices, Market Forecast, 2013-2018
  • Exhibit 2-8: 2013, Coronary Angiography Devices Market, Share by Supplier
  • Exhibit 2-9: Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes, 2013-2018
  • Exhibit 2-10: 2014, Selected Consoles and Guidewires for Physiologic Intravascular Stenosis Assessment
  • Exhibit 2-11: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2013-2018
  • Exhibit 2-12: 2013, Physiologic Intravascular Stenosis Assessment Guidewire Systems Market, Share by Supplier
  • Exhibit 2-13: Intracardiac Echocardiography, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-14: 2014, Selected Intracardiac Echocardiography Catheters
  • Exhibit 2-15: Intracardiac Echocardiography Catheters, Market Forecast, 2013-2018
  • Exhibit 2-16: 2013, Intracardiac Echocardiography Catheters Market, Share by Supplier
  • Exhibit 2-17: Intravascular Ultrasound, Procedure Volumes Forecast, 2013-2018
  • Exhibit 2-18: 2014, Selected Intravascular Ultrasound Products
  • Exhibit 2-19: Intravascular Ultrasound Products, Market Forecast, 2013-2018
  • Exhibit 2-20: 2013, Intravascular Ultrasound Products Market, Share by Supplier

3. THERAPEUTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS

  • 3.1. Percutaneous Transluminal Coronary Angioplasty
    • 3.1.1. Technologies
      • 3.1.1.1. Approaches
      • 3.1.1.2. Complications/Efficacy
    • 3.1.2. Procedure Volumes Forecast
    • 3.1.3. Products
      • 3.1.3.1. Balloon Catheters
      • 3.1.3.2. Guiding Catheters
      • 3.1.3.3. Guidewires
      • 3.1.3.4. Introducers/Sheaths
      • 3.1.3.5. Accessories
    • 3.1.4. Market Forecast
    • 3.1.5. Competitors
  • 3.2. Coronary Stenting
    • 3.2.1. Technologies
    • 3.2.2. Procedure Volumes Forecast
    • 3.2.3. Products
    • 3.2.4. Market Forecast
    • 3.2.5. Competitors
  • 3.3. Coronary Atherectomy
    • 3.3.1. Technologies
    • 3.3.2. Procedure Volumes Forecast
    • 3.3.3. Products
    • 3.3.4. Market Forecast
    • 3.3.5. Competitors
  • 3.4. Coronary Thrombectomy
    • 3.4.1. Technologies
    • 3.4.2. Procedures Volumes Forecast
    • 3.4.3. Products
    • 3.4.4. Market Forecast
    • 3.4.5. Competitors
  • 3.5. Transcatheter Septal Defect Repair
    • 3.5.1. Technologies
    • 3.5.2. Procedure Volumes Forecast
    • 3.5.3. Products
    • 3.5.4. Market Forecast
    • 3.5.5. Competitors
  • 3.6. Vascular Access Site Closure Devices
    • 3.6.1. Technologies
    • 3.6.2. Procedure Volumes Forecast
    • 3.6.3. Products
    • 3.6.4. Market Forecast
    • 3.6.5. Competitors
  • Exhibit 3-1: Therapeutic Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-2: Therapeutic Interventional Cardiology Products, Combined Market Forecast, 2013-2018
  • Exhibit 3-3: Percutaneous Transluminal Coronary Angioplasty, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-4: 2014, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters
  • Exhibit 3-5: 2014, Selected Guiding Catheters for Coronary Interventions
  • Exhibit 3-6: 2014, Selected Guidewires for Coronary Interventions
  • Exhibit 3-7: 2014, Selected Introducers/Sheaths for Coronary Interventions
  • Exhibit 3-8: 2014, Selected Inflation Devices for Coronary Interventions
  • Exhibit 3-9: Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2013-2018
  • Exhibit 3-10: 2013, Percutaneous Transluminal Coronary Angioplasty Devices Market, Share by Supplier
  • Exhibit 3-11: 2014, Selected Anti-Restenosis Agents
  • Exhibit 3-12: Coronary Stenting, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-13: 2014, Selected Coronary Stent Systems/Stents
  • Exhibit 3-14: Coronary Stent Systems, Market Forecast, 2013-2018
  • Exhibit 3-15: 2013, Coronary Stent Systems Market, Share by Supplier
  • Exhibit 3-16: Coronary Atherectomy, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-17: 2014, Selected Coronary Atherectomy Systems
  • Exhibit 3-18: Coronary Atherectomy Systems, Market Forecast, 2013-2018
  • Exhibit 3-19: 2013, Coronary Atherectomy Systems Market, Share by Supplier
  • Exhibit 3-20: Coronary Thrombectomy, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-21: 2014, Selected Thrombectomy Systems
  • Exhibit 3-22: Coronary Thrombectomy Systems, Market Forecast, 2013-2018
  • Exhibit 3-23: 2013, Coronary Thrombectomy Systems Market, Share by Supplier
  • Exhibit 3-24: Transcatheter Septal Defect Repair, Procedure Volumes Forecast, 2013-2018
  • Exhibit 3-25: 2014, Selected Transcatheter Septal Defect Repair Devices
  • Exhibit 3-26: Transcatheter Septal Defect Repair Devices, Market Forecast, 2013-2018
  • Exhibit 3-27: 2013, Transcatheter Septal Defect Repair Devices Market, Share by Supplier
  • Exhibit 3-28: Vascular Access Site Closure, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-29: 2014, Selected Vascular Site Closure Devices
  • Exhibit 3-30: Vascular Access Site Closure Devices, Market Forecast, 2013-2018
  • Exhibit 3-31: 2013, Vascular Access Site Closure Devices Market, Share by Supplier

APPENDIX: COMPANY LISTING

Back to Top